TARDIS statistics
info
Citations per year
info
Popular tool citations
chevron_left
Error correction
chevron_right
info
Related tools
info
Tool usage distribution map
info
Associated diseases
TARDIS specifications
Information
| Unique identifier | OMICS_32070 |
|---|---|
| Name | TARDIS |
| Alternative name | TARgeted DIgital Sequencing |
| Software type | Application/Script |
| Interface | Command line interface |
| Restrictions to use | None |
| Operating system | Unix/Linux |
| Programming languages | Python, Julia |
| Computer skills | Advanced |
| Stability | Stable |
| Requirements |
NumPy, SciPy, networkX, pandas, matplotlib
|
| Maintained | Yes |
Versioning
Add your version
Maintainer
- person_outline Muhammed Murtaza <>
Publication for TARgeted DIgital Sequencing
library_books
Detection of residual disease after neoadjuvant therapy in breast cancer using personalized circulating tumor DNA analysis.
2018 BioRxiv
DOI: 10.1101/425470
TARDIS institution(s)
Center for Noninvasive Diagnostics, Translational Genomics Research Institute, Phoenix, AZ, USA; University of Cambridge, Cambridge, UK; Mayo Clinic, Scottsdale, AZ, USA
TARDIS funding source(s)
Supported by Ben and Catherine Ivy Foundation, V Foundation for Cancer Research and Science Foundation Arizona, charitable donations from SmartPractice and support from NIH 1R01CA223481-01.
TARDIS reviews
Be the first to review TARDIS